Skip to content

EluNIR Ridaforolimus Eluting Coronary Stent System LUN250R12USRecalls & reported problems

Medinol Ltd. · Class 3 · Implant

All models of EluNIR Ridaforolimus Eluting Coronary Stent System (27)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290107013529), received between Dec 12, 2019 and Dec 12, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Thrombosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 12, 2019Insufficient Device Problem Information; Insufficient Device Problem Information

    ADDITIONAL INFORMATION (DATED DEC. 08, 2019). THE PHYSICIAN KNEW THAT THE STEMI WAS DUE TO IN-STENT THROMBOSIS BASED ON THE EKG FROM THE STEMI'S AND THE FACT THE STENTS WERE ALL SHUT DOWN IN BOTH PATIENTS.

    Patient problems: Thrombosis

    MAUDE report 9458212 ↗

Other Coronary Drug-Eluting Stent devices

All Coronary Drug-Eluting Stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page